Diazepam Nasal Spray (Valtoco®) Updates
 Earlier this year, Valtoco (diazepam nasal spray) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizure clusters and acute repetitive seizures. The makers of Valtoco have recently announced that it will now be available in pharmacies nationwide. Read the full press release from Neurelis, Inc. here.
Valtoco is currently approved for adult and pediatric patients six years of age and older. If you have questions about this medicine, please email info@neurelis.com 

Related Posts

SOAR Webinar

SOAR Webinar

**At this time, the SOAR study has reached capacity for conference participation. However, there still may be opportunities for research participation at the family conference due to cancellations or addition of other opportunities. If you would like to be placed on a...

FDA Issues Recall On Clonazepam Orally Disintegrating Tablets

FDA Issues Recall On Clonazepam Orally Disintegrating Tablets

The Dup15q Alliance is aware of the recent release by the FDA regarding Clonazepam Orally Disintegrating Tablets USP by Endo USA due to potential product carton strength mislabeling. Ongoing investigation identified the possibility that the affected clonazepam product...

Recall – Vigabatrin for Oral Solution USP

Recall – Vigabatrin for Oral Solution USP

TOPIC: Vigabatrin for Oral Solution USP, 500 mg by InvaGen Pharmaceuticals: Recall - Due to Leaking Sachets AUDIENCE: Patient, Health Professional, Pharmacy, Pediatric, Neurology ISSUE: InvaGen Pharmaceuticals is recalling one lot, NB301030, of Vigabatrin for Oral...